Semiconductors

Cellwise

Cellwise released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 106.97 M, actual EPS CNY 0.1288

Cellwise to Release FY2026 Q1 Earnings on April 30 After-Market (BJT)

Cellwise to release FY2025 earnings on April 3, Pre-Market BJT, forecast revenue CNY 464.39 M, EPS CNY 1.05

Cellwise released FY2025 Q4 earnings on February 27 Pre-Market (BJT), actual revenue CNY 144.65 M, actual EPS CNY 0.4061

Cellwise released FY2025 Annual Earnings on February 27 Pre-Market (BJT), actual revenue CNY 488.66 M (forecast CNY 464.39 M), actual EPS CNY 1.1238 (forecast CNY 1.05)

Cellwise released FY2025 Q3 earnings on October 28 After-Market (BJT), actual revenue CNY 125.61 M, actual EPS CNY 0.2595

Cellwise released FY2025 9 Months Earnings on October 28 After-Market BJT, actual revenue CNY 344.01 M, actual EPS CNY 0.7166

Cellwise FY2025 Q3 Earning Release on October 29, 2025 After-Market (BJT)

Cellwise released FY2025 Q2 earnings on August 26 After-Market BJT, actual revenue CNY 127.14 M, actual EPS CNY 0.2758

Cellwise released FY2025 Semi-Annual Earnings on August 26 After-Market BJT, with actual revenue of CNY 218.4 M and EPS of CNY 0.4571

Cellwise FY2025 Semi-Annual Earnings Release on August 27, 2025 (BJT)

Semiwee Electronics Sees 42.83% and 110.43% Q1 2025 Revenue and Net Profit Growth

Cellwise released FY2025 Q1 earnings on April 24 After-Market BJT, actual revenue CNY 91.26 M, actual EPS CNY 0.1813

Cellwise FY2025 Q1 Earnings Release on April 25 After-Market BJT

Saiwei Microelectronics Reports 2024 Revenue of 393 Million Yuan, Up 57.64%, Plans to Distribute Cash Dividend of 82.25 Million Yuan

Cellwise to Release FY2024 Annual Earnings on April 10 After-Market BJT, Forecast Revenue 284.64 M CNY, EPS 0.52 CNY

Juhua Investment Plans to Increase Shareholding in Saiwei Microelectronics

Cellwise released FY2024 Q4 earnings on February 27 After-Market (BJT), actual revenue CNY 111.9 M, actual EPS CNY 0.207

Cellwise released FY2024 Annual Earnings on February 27 After-Market BJT, actual revenue CNY 393.02 M (forecast CNY 284.64 M), actual EPS CNY 0.9186 (forecast CNY 0.52)

Cellwise released FY2024 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 114.4 M (forecast CNY 81.82 M), actual EPS CNY 0.361 (forecast CNY 0.18)

688325

Cellwise announced that it expects its 2025 operating revenue to be 489 million yuan, a year-on-year increase of 24.34%; net profit is expected to be 97.3449 million yuan, a year-on-year increase of 23.47%. The company plans to distribute a cash dividend of 13 yuan (inclusive of tax) per 10 shares to all shareholders, totaling a cash dividend distribution of 109 million yuan (inclusive of tax), accounting for 112.37% of its net profit

Wallstreetcn

Cellwise: 2025 Net Profit of 97.3449 Million Yuan, Up 23.47% Year-on-Year

Cellwise announced that its revenue for the third quarter was 126 million yuan, an increase of 9.80% year-on-year; net profit was 22.6577 million yuan, a decrease of 23.92%. Revenue for the first three quarters was 344 million yuan, an increase of 22.37% year-on-year; net profit was 62.0008 million yuan, an increase of 3.23%

Zhitong

Cellwise: Net profit for the third quarter was 22.6577 million yuan, a decrease of 23.92%

601069

301148

688114

On October 21, a total of 4 listed companies had their restricted shares unlocked, with a total market value of approximately 2.531 billion yuan. The specific situation of the restricted shares unlocked today is as follows: Stock Abbreviation Stock Code Restricted Share Type Unlocked Shares WESTERN REGION GOLD 601069 Equity Incentive Restricted Circulation 2.0741 million JIARONG 301148 Extended Restricted Lock-up Period Circulation 7.6832 million MGI 688114 1.2247 million Cellwise 688325 2.6157 million

WESTERN REGION GOLD

JIARONG

Zhitong A-share lock-up release overview | October 21

Cellwise rose 6.59%, closing at 93.02 yuan/share, with the stock price reaching a new high, total market value exceeding 8.012 billion yuan, and a trading volume of 248 million yuan

688498

688110

688593

688141

688048

The semiconductor sector experienced a volatile rebound, with Cellwise hitting the "20cm" daily limit, followed by gains in New Vision, YUANJIE SEMICONDUCTOR, JoulWatt, Everbright, Haiguang Information, and Dosilicon

YUANJIE SEMICONDUCTOR

Dosilicon

New Vision

JoulWatt

Everbright

The semiconductor sector fluctuated and rebounded, with Cellwise hitting the "20cm" daily limit

According to the Qichacha APP, recently, Nanjing Yuchuang Bangsheng Xintong Talent Venture Capital Partnership was established with a capital contribution of 120 million yuan. The business scope includes: venture capital; equity investment. Qichacha's equity penetration shows that this enterprise is jointly funded by Cellwise and others

Cellwise and others establish a new talent venture capital partnership in Nanjing

688262

688234

002077

688525

The semiconductor sector strengthened in the afternoon. As of the time of writing, SICC hit a 20% limit up, while JIANGSU DAGANG, Cellwise, Biwin, and C*Core Technology saw significant gains

C*Core Technology

SICC

JIANGSU DAGANG

Biwin

The semiconductor sector strengthened in the afternoon, with TianYue Advanced hitting a 20% limit up

Cellwise announced that Juhe Investment will increase its holdings of the company's shares by 25,000 shares from March 7, 2025, to September 4, 2025, with an increase amount of 1.0841 million yuan, accounting for 0.03% of the total share capital. The planned increase amount range is between 11.5 million yuan and 23 million yuan, with a planned period from March 7, 2025, to March 6, 2026. Juhe Investment will continue to implement the increase

Cellwise: Juhe Investment increased its stake by 0.03%

Cellwise announced that in the first half of 2025, operating revenue reached 218 million yuan, a year-on-year increase of 31.00%. Net profit was 39.3432 million yuan, a year-on-year increase of 29.91%

Cellwise: In the first half of 2025, net profit was 39.3432 million yuan, a year-on-year increase of 29.91%

Cellwise announced that shareholders holding more than 5% of the shares, Wu Yuefeng Investment and its concerted actors, plan to reduce their holdings by no more than 861,400 shares of the company's stock through centralized bidding within 15 trading days after the announcement, which accounts for approximately 1% of the total share capital. The shares to be reduced are from those held before the initial public offering, and the reason is funding needs. There is uncertainty regarding the implementation of the reduction plan

Cellwise: Wu Yuefeng and his concerted parties plan to reduce their holdings of the company's shares by no more than 1% in total

Cellwise(688325.SH)